Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients - Concepedia

Concepedia

Publication | Open Access

Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients

DOI Full Paper Access

26

Citations

23

References

2021

Year

Abdullah M. Al‐Rubaish, Fahad Al‐Muhanna, Abdullah Alshehri, Mohammed A. Al-Mansori, Rudaynah A. Alali, Rania M. Khalil, Khalid Al Faraidy, Cyril Cyrus, Mohammed M. Sulieman, Chittibabu Vatte,

International Journal of Cardiology

Abstract

A genotype-guided escalation of P2Y12 inhibitor strategy is feasible in STEMI patients treated with clopidogrel and undergoing PCI and is associated with a reduction of primary outcomes compared to conventional antiplatelet therapy.

References

	Year	Citations

Page 1